Paper 37 - TRABECTEDIN ADMINISTERED AS A 1-HOUR INFUSION IN COMBINATION WITH LOW DOSE IRINOTECAN IN PATIENTS WITH EWING SARCOMA: ANTI-TUMOR ACTIVITY AND REVERSAL OF THE EWS-FLI1 TRANSCRIPTOME

Author(s)

• 

  Patrick J. Grohar, MD, PhD

  Associate Professor of Pediatrics, Director of Translational Research
  Children’s Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States

  Slides

Co-Author(s)

• KB

  Karla V. Ballman, Ph.D.

  Professor of Population Health Science
  Weil Cornell Graduate School of Medical Sciences
  New York, New York, United States
• RH

  Rachel Heise, MS

  Weil Cornell Graduate School of Medical Sciences
  New York, New York, United States
• LS

  Lea Surrey, MD

  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States
• 

  Mary Frances Wedekind, DO

  Assistant Professor/Researcher
  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• 

  John Glod, MD, PhD (he/him/his)

  Clinical Director Pediatric Oncology Branch
  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• 

  Leo Mascarenhas, MD, MS (he/him/his)

  Associates Sarcoma Program Chair
  Children's Hospital Los Angeles, University of Southern California Keck School of Medicine
  Los Angeles, California, United States
• 

  Jenna Gedminas, MD

  Clinical Assistant Professor
  University of Iowa Hospitals and Clinics
  Iowa City, Iowa, United States
• SD

  Steven G. Dubois, MD, MS

  Associate Professor
  Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
  Boston, Massachusetts, United States
• 

  Robert G. Maki, MD PhD

  Member
  Memorial Sloan Kettering Cancer Center; Professor, Weill Cornell Medical College
  New York, New York, United States
• 

  Brian D. Crompton, MD

  Co-Director for Research, Pediatric Solid Tumor Program Assistant Professor of Pediatrics, Harvard Medical School Associate Member, Broad Institute of Harvard and MIT Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
  Dana-Farber/Boston Children's Cancer and Blood Disorders Center
  Boston, Massachusetts, United States
• 

  Masanori Hayashi, MD

  Assistant Professor
  Children's Hospital Colorado
  Aurora, Colorado, United States
• CP

  Cody Peer, PhD

  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• WF

  William D. Figg, Pharm.D.

  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• LL

  Liza Lindenberg, MD

  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• EM

  Esther Menagonzalez, MD

  Center for Cancer Research/National Cancer Institute
  Bethesda, Maryland, United States
• RB

  Rochelle Bagatell, MD

  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States
• LO

  Lindsey Overman, MS

  Sarcoma Alliance for Research through Collaboration
  Ann Arbor, Michigan, United States
• 

  Ryan D. Roberts, MD, PhD

  Associate Professor
  Nationwide Children's Hospital
  Columbus, Ohio, United States
• 

  Theodore W. Laetsch, MD

  Pediatric Oncologist
  Children’s Hospital of Philadelphia/University of Pennsylvania
  Philadelphia, Pennsylvania, United States
• BW

  Brigitte Widemann, MD

  National Cancer Institute
  Bethesda, Maryland, United States
• RK

  Rebecca Kaufman, MS

  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania, United States
• 

  Denise Reinke, MS, NP

  Sarcoma Nurse specialist/Patient Advocate
  University of Michigan
  Ann Arbor, Michigan, United States
• 

  Rashmi Chugh, MD

  University of Michigan Rogel Cancer Center
  Ann Arbor, Michigan, United States